Skip to main content

and
  1. Article

    Open Access

    Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)

    The composition of gut microbiota plays a pivotal role in priming the immune system and thus impacts autoimmune diseases. Data on the effects of gut bacteria eradication via systemic antibiotics on immune neur...

    Alina Sprenger-Svačina, Ines Klein in Journal of Neuroimmune Pharmacology (2024)

  2. Article

    Open Access

    Kinesin-5 inhibition improves neural regeneration in experimental autoimmune neuritis

    Autoimmune neuropathies can result in long-term disability and incomplete recovery, despite adequate first-line therapy. Kinesin-5 inhibition was shown to accelerate neurite outgrowth in different preclinical ...

    Felix Kohle, Robin Ackfeld, Franziska Hommen, Ines Klein in Journal of Neuroinflammation (2023)

  3. Article

    Open Access

    CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study

    Availability of COVID-19 mRNA vaccine for patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg) raises the question of whether COVID-19 mRNA vac...

    Martin K. R. Svačina, Anika Meißner in Journal of Neuroimmune Pharmacology (2023)

  4. No Access

    Article

    Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity

    Neurotoxicity is a relevant side effect of bortezomib treatment. Previous reports have shown that the development of peripheral neuropathy caused by anti-neoplastic agents may be a result of reduced axonal tra...

    Ilja Bobylev, Dominik Peters, Maulik Vyas, Mohammed Barham in Neurotoxicity Research (2017)